Ex-US revenue rose sharply by 21% YoY to Rs. 2, 240.4 crore ($254 million); Operational PAT grew 50.3% YoY to Rs. 518.1 crore
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
